The invention provides a compound of formula (I): wherein R1, R2,
R3, R4, R5, N, X and Y are as defined in the specification,
processes, for their preparation, pharmaceutical compositions containing them,
and their use in therapy, especially for the treatment of chemokine receptor related
diseases and conditions.